United States Biotechnology & Medical Research

Immuneering Corp (IMRX)

Track

Over the past 90 days, Immuneering Corp has seen two insider transactions, both involving executive purchases totaling $35,993.33. These acquisitions by the CEO and Chief Scientific Officer occurred following the company's May 2026 earnings report, which showed a 40% EPS beat. The stock has experienced a 16.1% decline over the same period.
Ticker: IMRX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Immuneering Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Zeskind Benjamin J.
PRESIDENT AND CEO
1 purchase — total 10,948 USD
Buy 23 Jun 2026
Value US$2,498,422.13 | Price 233.88 | Shares 39,378
Buy 15 Jun 2026
Value US$4,013,256.69 | Price 274.22 | Shares 19,997
Buy 16 Jan 2026
Value US$24,990.00 | Price 4.76 | Shares 5,250
Buy 15 Jan 2026
Value US$101,041.02 | Price 4.67 | Shares 21,645
Buy 15 Jan 2026
Value US$10,501.86 | Price 4.57 | Shares 2,298
Buy 13 Jan 2026
Value US$10,905.78 | Price 4.15 | Shares 2,626
Buy 12 Jan 2026
Value US$86,904.00 | Price 4.35 | Shares 20,000
Buy 3 Oct 2025
Value US$50,025.00 | Price 6.67 | Shares 7,500
Buy 1 Oct 2025
Value US$1,917.00 | Price 6.39 | Shares 300
Buy 1 Oct 2025
Value US$5,103.36 | Price 6.38 | Shares 800
Buy 1 Oct 2025
Value US$6,966.50 | Price 6.83 | Shares 1,020
Buy 30 Sep 2025
Value US$52,730.25 | Price 7.03 | Shares 7,500
Buy 29 Sep 2025
Value US$35,900.00 | Price 7.18 | Shares 5,000
Proposed sale 23 Sep 2025
Value US$136,080.00 | Price 9.72 | Shares 14,000
Buy 2 Jul 2025
Value US$2,498.65 | Price 3.57 | Shares 700
Buy 2 Jul 2025
Value US$10,873.50 | Price 3.62 | Shares 3,000
Buy 2 Jul 2025
Value US$8,989.00 | Price 3.60 | Shares 2,500
Buy 2 Jul 2025
Value US$24,792.41 | Price 3.53 | Shares 7,015
Buy 1 Jul 2025
Value US$10,086.91 | Price 3.38 | Shares 2,985
Buy 27 Jun 2025
Value US$34,788.05 | Price 3.66 | Shares 9,500
Buy 23 Jun 2025
Value US$14,596.41 | Price 2.43 | Shares 6,007
Buy 20 Jun 2025
Value US$20,019.76 | Price 2.70 | Shares 7,415
Buy 20 Jun 2025
Value US$4,804.15 | Price 2.53 | Shares 1,900
Buy 18 Jun 2025
Value US$63,187.50 | Price 2.53 | Shares 25,000
Buy 18 Jun 2025
Value US$50,143.80 | Price 2.39 | Shares 21,000
Buy 17 Jun 2025
Value US$89,277.52 | Price 2.21 | Shares 40,485
Sale 1 Apr 2024
Value US$1,155,940.00 | Price 2.90 | Shares 398,600
Sale 1 Apr 2024
Value US$831.60 | Price 2.97 | Shares 280
Sale 1 Apr 2024
Value US$29.80 | Price 2.98 | Shares 10
Sale 1 Apr 2024
Value US$30.10 | Price 3.01 | Shares 10
Sale 1 Apr 2024
Value US$1,818.00 | Price 3.03 | Shares 600
Sale 1 Apr 2024
Value US$305.00 | Price 3.05 | Shares 100
Sale 1 Apr 2024
Value US$919.50 | Price 3.07 | Shares 300
Sale 1 Apr 2024
Value US$307.00 | Price 3.07 | Shares 100
Buy 22 Mar 2024
Value US$7,384.85 | Price 2.55 | Shares 2,900
Buy 22 Mar 2024
Value US$63,712.50 | Price 2.55 | Shares 25,000
Buy 22 Mar 2024
Value US$10,015.20 | Price 2.57 | Shares 3,900
Buy 22 Mar 2024
Value US$1,000.38 | Price 2.55 | Shares 393
Buy 21 Mar 2024
Value US$3,008.72 | Price 2.72 | Shares 1,107
Buy 20 Mar 2024
Value US$20,020.00 | Price 2.86 | Shares 7,000
Buy 20 Mar 2024
Value US$10,993.17 | Price 2.88 | Shares 3,818
Buy 19 Mar 2024
Value US$64,000.00 | Price 2.56 | Shares 25,000
Buy 19 Mar 2024
Value US$55,326.00 | Price 2.77 | Shares 20,000
Buy 18 Mar 2024
Value US$15,201.18 | Price 3.05 | Shares 4,976
Buy 18 Mar 2024
Value US$103,856.86 | Price 2.31 | Shares 45,024
Buy 18 Mar 2024
Value US$123,436.47 | Price 2.13 | Shares 57,965
Sale 15 Mar 2024
Value US$856,400.00 | Price 2.14 | Shares 400,000
Sale 14 Mar 2024
Value US$65,886.72 | Price 5.97 | Shares 11,040
Sale 14 Mar 2024
Value US$291,351.41 | Price 5.37 | Shares 54,215
Sale 14 Mar 2024
Value US$418,429.65 | Price 4.25 | Shares 98,570
Sale 14 Mar 2024
Value US$1,116,935.51 | Price 3.24 | Shares 345,266
Buy 25 May 2022
Value US$9,999.92 | Price 3.92 | Shares 2,551
Buy 17 May 2022
Value US$4,880.00 | Price 4.88 | Shares 1,000
Buy 16 May 2022
Value US$35,000.00 | Price 5.00 | Shares 7,000
Buy 12 May 2022
Value US$4,420.00 | Price 4.42 | Shares 1,000
Buy 23 Mar 2022
Value US$24,060.00 | Price 8.02 | Shares 3,000
Buy 23 Mar 2022
Value US$8,305.50 | Price 7.91 | Shares 1,050
Buy 22 Mar 2022
Value US$6,736.50 | Price 7.49 | Shares 900
Buy 15 Mar 2022
Value US$45,002.25 | Price 6.75 | Shares 6,667
Buy 15 Mar 2022
Value US$38,400.00 | Price 6.40 | Shares 6,000
Buy 13 Sep 2021
Value US$47,631.96 | Price 22.87 | Shares 2,083
Buy 3 Aug 2021
Value US$499,995.00 | Price 15.00 | Shares 33,333
Buy 3 Aug 2021
Value US$1,937,505.00 | Price 15.00 | Shares 129,167
Buy 3 Aug 2021
Value US$1,937,505.00 | Price 15.00 | Shares 129,167
Buy 3 Aug 2021
Value US$62,625.00 | Price 15.00 | Shares 4,175
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-24 2026-06-23 B Purchase
3.4
Zeskind Benjamin J.

PRESIDENT AND CEO

Executive Director
39,378 -15.5%
233.88
US$2,498,422 		39,378 -15.5% 233.88 US$2,498,422
2026-06-16 2026-06-15 B Purchase
3.9
Hall Brett Matthew

CHIEF SCIENTIFIC OFFICER

Officer
19,997 -4.3%
274.22
US$4,013,257 		19,997 -4.3% 274.22 US$4,013,257
2026-01-21 2026-01-16 B Purchase
3.3
Brakewood Harold Eugene

Chief Business Officer

Officer
23,955 -38.3%
179.63
US$3,991,038 		23,955 -38.3% 179.63 US$3,991,038
2026-01-20 2026-01-15 B Purchase
4.0
Schall Thomas J.
Non-Executive Director
21,645 +40.9%
4.67
US$101,041 		21,645 +40.9% 4.67 US$101,041
2026-01-16 2026-01-15 B Purchase
3.9
Hall Brett Matthew

CHIEF SCIENTIFIC OFFICER

Officer
2,298 +0.6%
4.57
US$10,502 		2,298 +0.6% 4.57 US$10,502
2026-01-15 2026-01-13 B Purchase
2.6
Neufeld Leah R

CHIEF PEOPLE OFFICER

Officer
2,626 +11.2%
4.15
US$10,906 		2,626 +11.2% 4.15 US$10,906
2026-01-14 2026-01-12 B Purchase
2.6
Feinberg Peter
Non-Executive Director
20,000 +17.3%
4.35
US$86,904 		20,000 +17.3% 4.35 US$86,904
2025-10-07 2025-10-03 B Purchase
2.6
Feinberg Peter
Non-Executive Director
7,500 +5.0%
6.67
US$50,025 		7,500 +5.0% 6.67 US$50,025
2025-10-02 2025-10-01 B Purchase
1.4
Morales Mallory

Chief Accounting Officer

Officer
300 +1.1%
6.39
US$1,917 		300 +1.1% 6.39 US$1,917
2025-10-02 2025-10-01 B Purchase
2.6
Neufeld Leah R

CHIEF PEOPLE OFFICER

Officer
800 +3.5%
6.38
US$5,103 		800 +3.5% 6.38 US$5,103
2025-10-02 2025-10-01 B Purchase
2.8
Bookman Michael

CHIEF LEGAL OFFICER, SECRETARY

Officer
1,020 +26.5%
6.83
US$6,966 		1,020 +26.5% 6.83 US$6,966
2025-10-01 2025-09-30 B Purchase
2.6
Feinberg Peter
Non-Executive Director
7,500 +5.3%
7.03
US$52,730 		7,500 +5.3% 7.03 US$52,730
2025-09-30 2025-09-29 B Purchase
2.6
Feinberg Peter
Non-Executive Director
5,000 +3.7%
7.18
US$35,900 		5,000 +3.7% 7.18 US$35,900
2025-09-23 2025-09-23 PrS Proposed sale
3.0
BERMAN ANN E

Director

Non-Executive Director
14,000
9.72
US$136,080 		14,000 9.72 US$136,080
2025-07-07 2025-07-02 B Purchase
2.6
Neufeld Leah R

CHIEF PEOPLE OFFICER

Officer
700 +7.0%
3.57
US$2,499 		700 +7.0% 3.57 US$2,499
2025-07-07 2025-07-02 B Purchase
3.7
HAUSMAN DIANA
Non-Executive Director
3,000 +inf%
3.62
US$10,874 		3,000 +inf% 3.62 US$10,874
2025-07-07 2025-07-02 B Purchase
3.7
HAUSMAN DIANA
Non-Executive Director
2,500 +inf%
3.60
US$8,989 		2,500 +inf% 3.60 US$8,989
2025-07-03 2025-07-02 B Purchase
3.4
Zeskind Benjamin J.

PRESIDENT AND CEO

Executive Director Large shareholder
7,015 +0.3%
3.53
US$24,792 		7,015 +0.3% 3.53 US$24,792
2025-07-03 2025-07-01 B Purchase
3.4
Zeskind Benjamin J.

PRESIDENT AND CEO

Executive Director Large shareholder
2,985 +0.1%
3.38
US$10,087 		2,985 +0.1% 3.38 US$10,087
2025-06-30 2025-06-27 B Purchase
4.0
Schall Thomas J.
Non-Executive Director
9,500 +21.9%
3.66
US$34,788 		9,500 +21.9% 3.66 US$34,788
2025-06-24 2025-06-23 B Purchase
3.9
Hall Brett Matthew

CHIEF SCIENTIFIC OFFICER

Officer
6,007 +1.7%
2.43
US$14,596 		6,007 +1.7% 2.43 US$14,596
2025-06-24 2025-06-20 B Purchase
3.9
Hall Brett Matthew

CHIEF SCIENTIFIC OFFICER

Officer
7,415 +2.1%
2.70
US$20,020 		7,415 +2.1% 2.70 US$20,020
2025-06-24 2025-06-20 B Purchase
3.3
Brakewood Harold Eugene

Chief Business Officer

Officer
1,900 +48.7%
2.53
US$4,804 		1,900 +48.7% 2.53 US$4,804
2025-06-23 2025-06-18 B Purchase
2.6
Feinberg Peter
Non-Executive Director
25,000 +22.4%
2.53
US$63,188 		25,000 +22.4% 2.53 US$63,188
2025-06-20 2025-06-18 B Purchase
3.4
Zeskind Benjamin J.

PRESIDENT AND CEO

Executive Director Large shareholder
21,000 +0.9%
2.39
US$50,144 		21,000 +0.9% 2.39 US$50,144
2025-06-18 2025-06-17 B Purchase
4.0
Schall Thomas J.
Non-Executive Director
40,485 +1396.0%
2.21
US$89,278 		40,485 +1396.0% 2.21 US$89,278
2024-04-03 2024-04-01 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
398,600 -12.1%
2.90
US$1,155,940 		398,600 -12.1% 2.90 US$1,155,940
2024-04-03 2024-04-01 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
280 -0.0%
2.97
US$832 		280 -0.0% 2.97 US$832
2024-04-03 2024-04-01 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
10 -0.0%
2.98
US$30 		10 -0.0% 2.98 US$30
2024-04-03 2024-04-01 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
10 -0.0%
3.01
US$30 		10 -0.0% 3.01 US$30
2024-04-03 2024-04-01 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
600 -0.0%
3.03
US$1,818 		600 -0.0% 3.03 US$1,818
2024-04-03 2024-04-01 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
100 -0.0%
3.05
US$305 		100 -0.0% 3.05 US$305
2024-04-03 2024-04-01 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
300 -0.0%
3.07
US$920 		300 -0.0% 3.07 US$920
2024-04-03 2024-04-01 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
100 -0.0%
3.07
US$307 		100 -0.0% 3.07 US$307
2024-03-25 2024-03-22 B Purchase
4.0
Schall Thomas J.
Non-Executive Director
2,900 +inf%
2.55
US$7,385 		2,900 +inf% 2.55 US$7,385
2024-03-25 2024-03-22 B Purchase
2.6
Feinberg Peter
Non-Executive Director
25,000 +28.8%
2.55
US$63,712 		25,000 +28.8% 2.55 US$63,712
2024-03-25 2024-03-22 B Purchase
3.3
Brakewood Harold Eugene

Chief Business Officer

Officer
3,900 +inf%
2.57
US$10,015 		3,900 +inf% 2.57 US$10,015
2024-03-25 2024-03-22 B Purchase
1.4
Morales Mallory

Chief Accounting Officer

Officer
393 +5.0%
2.55
US$1,000 		393 +5.0% 2.55 US$1,000
2024-03-25 2024-03-21 B Purchase
1.4
Morales Mallory

Chief Accounting Officer

Officer
1,107 +16.3%
2.72
US$3,009 		1,107 +16.3% 2.72 US$3,009
2024-03-21 2024-03-20 B Purchase
3.9
Hall Brett Matthew

CHIEF SCIENTIFIC OFFICER

Officer
7,000 +2.1%
2.86
US$20,020 		7,000 +2.1% 2.86 US$20,020
2024-03-21 2024-03-20 B Purchase
2.6
Neufeld Leah R

CHIEF PEOPLE OFFICER

Officer
3,818 +61.5%
2.88
US$10,993 		3,818 +61.5% 2.88 US$10,993
2024-03-19 2024-03-19 B Purchase
2.6
Feinberg Peter
Non-Executive Director
25,000 +40.5%
2.56
US$64,000 		25,000 +40.5% 2.56 US$64,000
2024-03-19 2024-03-19 B Purchase
3.4
Zeskind Benjamin J.

PRESIDENT AND CEO

Executive Director Large shareholder
20,000 +0.9%
2.77
US$55,326 		20,000 +0.9% 2.77 US$55,326
2024-03-19 2024-03-18 B Purchase
2.6
Feinberg Peter
Non-Executive Director
4,976 +8.8%
3.05
US$15,201 		4,976 +8.8% 3.05 US$15,201
2024-03-19 2024-03-18 B Purchase
2.6
Feinberg Peter
Non-Executive Director
45,024 +382.7%
2.31
US$103,857 		45,024 +382.7% 2.31 US$103,857
2024-03-19 2024-03-18 B Purchase
3.0
BERMAN ANN E
Non-Executive Director
57,965 +610.2%
2.13
US$123,436 		57,965 +610.2% 2.13 US$123,436
2024-03-18 2024-03-15 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
400,000 -10.8%
2.14
US$856,400 		400,000 -10.8% 2.14 US$856,400
2024-03-18 2024-03-14 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
11,040 -0.3%
5.97
US$65,887 		11,040 -0.3% 5.97 US$65,887
2024-03-18 2024-03-14 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
54,215 -1.4%
5.37
US$291,351 		54,215 -1.4% 5.37 US$291,351
2024-03-18 2024-03-14 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
98,570 -2.6%
4.25
US$418,430 		98,570 -2.6% 4.25 US$418,430
2024-03-18 2024-03-14 S Sale
3.7
Cormorant Asset Management, LP
Large shareholder
345,266 -8.2%
3.24
US$1,116,936 		345,266 -8.2% 3.24 US$1,116,936
2022-05-27 2022-05-25 B Purchase
3.9
Hall Brett Matthew

CHIEF SCIENTIFIC OFFICER

Officer
2,551 +0.8%
3.92
US$10,000 		2,551 +0.8% 3.92 US$10,000
2022-05-18 2022-05-17 B Purchase
2.8
Bookman Michael

GENERAL COUNSEL AND SECRETARY

Officer
1,000 +71.3%
4.88
US$4,880 		1,000 +71.3% 4.88 US$4,880
2022-05-17 2022-05-16 B Purchase
2.2
KEATING LAURIE
Non-Executive Director
7,000 +100.0%
5.00
US$35,000 		7,000 +100.0% 5.00 US$35,000
2022-05-12 2022-05-12 B Purchase
3.2
Amin Biren

CFO, TREASURER

Officer
1,000 +14.5%
4.42
US$4,420 		1,000 +14.5% 4.42 US$4,420
2022-03-24 2022-03-23 B Purchase
3.4
Zeskind Benjamin J.

PRESIDENT AND CEO

Executive Director Large shareholder
3,000 +0.1%
8.02
US$24,060 		3,000 +0.1% 8.02 US$24,060
2022-03-23 2022-03-23 B Purchase
3.9
Hall Brett Matthew

CHIEF SCIENTIFIC OFFICER

Officer
1,050 +0.3%
7.91
US$8,306 		1,050 +0.3% 7.91 US$8,306
2022-03-22 2022-03-22 B Purchase
2.1
Barrett Scott

CHIEF MEDICAL OFFICER

Officer
900 +13.5%
7.49
US$6,736 		900 +13.5% 7.49 US$6,736
2022-03-16 2022-03-15 B Purchase
2.6
Feinberg Peter
Non-Executive Director
6,667 +130.8%
6.75
US$45,002 		6,667 +130.8% 6.75 US$45,002
2022-03-15 2022-03-15 B Purchase
3.0
BERMAN ANN E
Non-Executive Director
6,000 +171.4%
6.40
US$38,400 		6,000 +171.4% 6.40 US$38,400
2021-09-14 2021-09-13 B Purchase
3.4
Zeskind Benjamin J.

PRESIDENT AND CEO

Executive Director Large shareholder
2,083 +0.1%
22.87
US$47,632 		2,083 +0.1% 22.87 US$47,632
2021-08-04 2021-08-03 B Purchase
2.6
Feinberg Peter
Non-Executive Director
33,333 +40.6%
15.00
US$499,995 		33,333 +40.6% 15.00 US$499,995
2021-08-04 2021-08-03 B Purchase
2.6
Feinberg Peter
Non-Executive Director
129,167 +37.2%
15.00
US$1,937,505 		129,167 +37.2% 15.00 US$1,937,505
2021-08-04 2021-08-03 B Purchase
2.6
Feinberg Peter
Non-Executive Director
129,167 +50.2%
15.00
US$1,937,505 		129,167 +50.2% 15.00 US$1,937,505
2021-08-04 2021-08-03 B Purchase
3.2
Amin Biren

CFO, Treasurer

Officer
4,175 +153.3%
15.00
US$62,625 		4,175 +153.3% 15.00 US$62,625
Explore more

More insider trading research around Immuneering Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America